Joni R. Beshansky

Joni R. Beshansky, RN, MPH, LP.D.

Associate Faculty Director, Master of Science in Bioethics Program
Lecturer, Department of Global Health and Social Medicine, HMS

Joni R. Beshansky, RN, MPH, LP.D. is faculty at the Center for Bioethics and Global Health and Social Medicine at Harvard Medical School (HMS), where she is also Associate Faculty Director of the Master of Bioethics (MBE) program, Co-Director of the MBE Virtual Program, and the Co-Director of the MBE Capstone Program. She received a Master of Public Health from Boston University, a Doctor of Law and Policy from Northeastern University, and completed a Fellowship in Bioethics at Harvard Medical School’s Center for Bioethics. She has been published in a number of academic journals highlighting her work as a clinical scientist and investigator-initiated researcher focusing on cardiovascular disease and emergency medicine, all supported by federal grants during her tenure at Tufts University School of Medicine. As an educator, Dr. Beshansky was the director of graduate programs that focused on regulatory affairs and clinical research, health administration, and clinical translational science prior to joining HMS. A transdisciplinary career informs her bioethical interests of equity, inclusivity, social justice, informed consent, health policy, and applying an ethical lens to decision-making, together allowing her to address broader societal issues and guide individuals to become ethical healthcare leaders.

Publications View
In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: results from the IMMEDIATE Trial.
Authors: Authors: Mukherjee JT, Beshansky JR, Ruthazer R, Alkofide H, Ray M, Kent D, Manning WJ, Huggins GS, Selker HP.
Cardiovasc Ultrasound
View full abstract on Pubmed
Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.
Authors: Authors: Selker HP, Harris WS, Rackley CE, Marsh JB, Ruthazer R, Beshansky JR, Rashba EJ, Peter I, Opie LH.
Am Heart J
View full abstract on Pubmed
C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.
Authors: Authors: Alkofide H, Huggins GS, Beshansky JR, Ruthazer R, Peter I, Ray M, Mukherjee JT, Selker HP.
BMC Cardiovasc Disord
View full abstract on Pubmed
A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study,,.
Authors: Authors: Ray M, Ruthazer R, Beshansky JR, Kent DM, Mukherjee JT, Alkofide H, Selker HP.
Int J Cardiol Heart Vasc
View full abstract on Pubmed
Serum adiponectin levels in patients with acute coronary syndromes: Serial changes and relation to infarct size.
Authors: Authors: Alkofide H, Huggins GS, Ruthazer R, Beshansky JR, Selker HP.
Diab Vasc Dis Res
View full abstract on Pubmed
One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE Trial)
Authors:
Am J Cardiol
View full abstract on Pubmed
A community consultation survey to evaluate support for and success of the IMMEDIATE trial.
Authors: Authors: Beshansky JR, Sheehan PR, Klima KJ, Hadar N, Vickery EM, Selker HP.
Clin Trials
View full abstract on Pubmed